ES2186615T3 - Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. - Google Patents

Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Info

Publication number
ES2186615T3
ES2186615T3 ES00400286T ES00400286T ES2186615T3 ES 2186615 T3 ES2186615 T3 ES 2186615T3 ES 00400286 T ES00400286 T ES 00400286T ES 00400286 T ES00400286 T ES 00400286T ES 2186615 T3 ES2186615 T3 ES 2186615T3
Authority
ES
Spain
Prior art keywords
erythromycin
medications
application
preparation procedure
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00400286T
Other languages
English (en)
Inventor
Alexis Denis
Claude Fromentin
Bertrand Heckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2186615T3 publication Critical patent/ES2186615T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos de fórmula (I) así como sus sales de adición con ácidos: **(Figura)** en la que X representa un radical CH2 o NH, n representa un número entero comprendido entre 1 y 8, Y representa un átomo de hidrógeno o halógeno, R representa un radical: **(Figura)** y Z representa un átomo de hidrógeno o el resto de un ácido.
ES00400286T 1999-02-04 2000-02-03 Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. Expired - Lifetime ES2186615T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901292A FR2789392B1 (fr) 1999-02-04 1999-02-04 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ES2186615T3 true ES2186615T3 (es) 2003-05-16

Family

ID=9541593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00400286T Expired - Lifetime ES2186615T3 (es) 1999-02-04 2000-02-03 Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Country Status (8)

Country Link
US (1) US6313101B1 (es)
EP (1) EP1026170B1 (es)
JP (2) JP5019665B2 (es)
AT (1) ATE231160T1 (es)
DE (1) DE60001182T2 (es)
DK (1) DK1026170T3 (es)
ES (1) ES2186615T3 (es)
FR (1) FR2789392B1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EE200100613A (et) * 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN104860943B (zh) * 2015-05-18 2017-11-17 上海毕路得医药科技有限公司 5,7‑二氯‑1h‑咪唑并[4,5‑b]吡啶的合成方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
EP1026170A1 (fr) 2000-08-09
JP5222348B2 (ja) 2013-06-26
EP1026170B1 (fr) 2003-01-15
DK1026170T3 (da) 2003-05-05
FR2789392B1 (fr) 2001-10-05
JP5019665B2 (ja) 2012-09-05
FR2789392A1 (fr) 2000-08-11
DE60001182T2 (de) 2003-10-09
ATE231160T1 (de) 2003-02-15
JP2011136990A (ja) 2011-07-14
JP2000229993A (ja) 2000-08-22
US6313101B1 (en) 2001-11-06
DE60001182D1 (de) 2003-02-20

Similar Documents

Publication Publication Date Title
DK1026170T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
PT897904E (pt) 2-metoxibenzofenonas fungicidas
PT865281E (pt) Derivados de benzimidazole substituidos por naftilo como anticoagulantes
EA200201083A1 (ru) Противоопухолевые производные эктейнасцидина
ATE278661T1 (de) Anthranilsäurederivate
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
EA200100983A1 (ru) Производные 13-метилэритромицина
EP1029860A4 (en) BENZOFURANE DERIVATIVES
DE69921151D1 (de) Fluorszierende marker
EP1465625A4 (en) SOLUBLY MADE TOPOISOMERASE GIFTS
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
DE69512310D1 (de) Glukopyranosid-Benzothiophene
FR2787109B1 (fr) Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA200100967A1 (ru) Новое иммунодепрессивное средство
ATE206125T1 (de) Furoindolizine
DE60039695D1 (de) Antifucoidan antikörper
ATE242227T1 (de) Tetrahydrofuranderivate
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
DE60102113D1 (de) Ammonium-3,5,6-trihydroxyhexansäure-Derivate und Methoden zu ihrer Herstellung
NZ506616A (en) Barbituric acid derivative for the treatment of bone and cartilage disorders